Comparative functional characterization of canine IgG subclasses

• Published in: Veterinary immunology and immunopathology 2014-01, Vol.157 (1-2), p.31-41
• Main Authors: Bergeron, Lisa M., McCandless, Erin E., Dunham, Steve, Dunkle, Bill, Zhu, Yaqi, Shelly, John, Lightle, Sandra, Gonzales, Andrea, Bainbridge, Graeme
• Format: Article
• Language: English
• Subjects: Animals; Antibody-Dependent Cell Cytotoxicity - immunology; Canine; Cloning, Molecular; Cross Reactions - immunology; Dogs - immunology; Effector functions; Fc receptor; Humans; IgG subclass; Immunoglobulin; Immunoglobulin G - immunology; Mice; Random Amplified Polymorphic DNA Technique - veterinary; Receptors, IgG - genetics; Receptors, IgG - immunology; Recombinant Fusion Proteins - genetics; Recombinant Fusion Proteins - immunology; RNA - chemistry; RNA - genetics
• ISSN: 0165-2427; 1873-2534
• DOI: 10.1016/j.vetimm.2013.10.018

To date, very little is known about the functional characteristics of the four published canine IgG subclasses. It is not clear how each subclass engages the immune system via complement-dependent cytotoxicity (CDC) or antibody-dependent cell-mediated cytotoxicity (ADCC), or how long each antibody may last in serum. Such information is critical for understanding canine immunology and for the discovery of canine therapeutic monoclonal antibodies. Through both in vitro and ex vivo experiments to evaluate canine Fc's for effector function, complement binding, FcRn binding, and ADCC, we are now able to categorize canine subclasses by function. The subclasses share functional properties with the four human IgG subclasses and are reported herein with their function-based human analog. Canine Fc fusions, canine chimeras, and caninized antibodies were characterized. Canine subclasses A and D appear effector-function negative while subclasses B and C bind canine Fc gamma receptors and are positive for ADCC. All canine subclasses bind the neonatal Fc receptor except subclass C. By understanding canine IgGs in this way, we can apply what is known of human immunology toward translational and veterinary medicine. Thus, this body of work lays the foundation for evaluating canine IgG subclasses for therapeutic antibody development and builds upon the fundamental scholarship of canine immunology.